Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Byun, Kyunghee | - |
dc.contributor.author | Yoo, YongCheol | - |
dc.contributor.author | Son, Myeongjoo | - |
dc.contributor.author | Lee, Jaesuk | - |
dc.contributor.author | Jeong, Goo-Bo | - |
dc.contributor.author | Park, Young Mok | - |
dc.contributor.author | Salekdeh, Ghasem Hosseini | - |
dc.contributor.author | Lee, Bonghee | - |
dc.date.available | 2020-02-27T17:42:34Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-09 | - |
dc.identifier.issn | 0163-7258 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5739 | - |
dc.description.abstract | Advanced glycation end products (AGEs) and their receptor have been implicated in the progressions of many intractable diseases, such as diabetes and atherosclerosis, and are also critical for pathologic changes in chronic degenerative diseases, such as Alzheimer's disease, Parkinson's disease, and alcoholic brain damage. Recently activated macrophages were found to be a source of AGEs, and the most abundant form of AGEs, AGE-albumin excreted by macrophages has been implicated in these diseases and to act through common pathways. AGEs inhibition has been shown to prevent the pathogenesis of AGEs-related diseases in human, and therapeutic advances have resulted in several agents that prevent their adverse effects. Recently, anti-inflammatory molecules that inhibit AGEs have been shown to be good candidates for ameliorating diabetic complications as well as degenerative diseases. This review was undertaken to present, discuss, and clarify current understanding regarding AGEs formation in association with macrophages, different diseases, therapeutic and diagnostic strategy and links with RAGE inhibition. (C)2017 The Author(s). Published by Elsevier Inc. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.relation.isPartOf | PHARMACOLOGY & THERAPEUTICS | - |
dc.subject | NF-KAPPA-B | - |
dc.subject | CALCIUM-BINDING PROTEINS | - |
dc.subject | MOBILITY GROUP BOX-1 | - |
dc.subject | ALPHA-LIPOIC ACID | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | MITOCHONDRIAL DYSFUNCTION | - |
dc.subject | GENE-EXPRESSION | - |
dc.subject | IN-VITRO | - |
dc.subject | NITRIC-OXIDE | - |
dc.subject | HMGB1 PHOSPHORYLATION | - |
dc.title | Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000411547400005 | - |
dc.identifier.doi | 10.1016/j.pharmthera.2017.02.030 | - |
dc.identifier.bibliographicCitation | PHARMACOLOGY & THERAPEUTICS, v.177, pp.44 - 55 | - |
dc.identifier.scopusid | 2-s2.0-85014995461 | - |
dc.citation.endPage | 55 | - |
dc.citation.startPage | 44 | - |
dc.citation.title | PHARMACOLOGY & THERAPEUTICS | - |
dc.citation.volume | 177 | - |
dc.contributor.affiliatedAuthor | Byun, Kyunghee | - |
dc.contributor.affiliatedAuthor | Son, Myeongjoo | - |
dc.contributor.affiliatedAuthor | Lee, Jaesuk | - |
dc.contributor.affiliatedAuthor | Jeong, Goo-Bo | - |
dc.contributor.affiliatedAuthor | Lee, Bonghee | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Advanced glycation end products (AGES) | - |
dc.subject.keywordAuthor | Receptor for AGES (RAGE) | - |
dc.subject.keywordAuthor | Macrophage | - |
dc.subject.keywordAuthor | Inflammation | - |
dc.subject.keywordAuthor | Degenerative diseases | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | CALCIUM-BINDING PROTEINS | - |
dc.subject.keywordPlus | MOBILITY GROUP BOX-1 | - |
dc.subject.keywordPlus | ALPHA-LIPOIC ACID | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | MITOCHONDRIAL DYSFUNCTION | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | NITRIC-OXIDE | - |
dc.subject.keywordPlus | HMGB1 PHOSPHORYLATION | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.